Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-23 | New | $29,441,931 | $29,441,931 | Debt Only | 06b | SEC link |
| 2023-09-28 | Amended | $259,799,396 | $49,799,374 | Equity Only | 06b | SEC link |
| 2023-01-27 | Amended | $210,000,022 | $50,000,013 | Equity and Debt | 06b | SEC link |
| 2022-07-06 | Amended | $160,000,009 | $119,999,967 | Equity Only | 06b | SEC link |
| 2021-10-25 | New | $40,000,042 | $40,000,042 | Equity Only | 06b | SEC link |
| 2020-03-20 | New | $27,499,993 | $27,499,993 | Equity Only | 06b | SEC link |
| 2019-02-08 | Amended | $2,000,000 | $1,000,000 | Equity Only | 06b | SEC link |
| 2017-03-02 | Amended | $1,000,000 | $500,000 | Equity Only | 06b | SEC link |
| 2017-01-05 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Rana Al Hallaq | Director |
| Alan Colowick | Director |
| Rakhshita Dhar | Director |
| Julia Eastland | Executive |
| Kouki Harasaki | Director |
| Edward Hurwitz | Director |
| Arthur E Johnson | Director, Executive |
| Helen S. Kim | Director |
| David Lockhart | Executive |
| Trisha Millican | Director |
| Patricia Millican | Director |
| Dean Mitchell | Director |
| Oleg Nodelman | Director |
| Inai Park | Director |
| Ra Session Ii | Director |
| Shehnaaz Suliman | Director, Executive |
| Peter A. Thompson | Director |
| Michael Torres | Director |
| Basheer Zada | Director |